Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease
- PMID: 21787353
- DOI: 10.1042/BST0391086
Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease
Abstract
A20 [also known as TNFAIP3 (tumour necrosis factor α-induced protein 3)] restricts and terminates inflammatory responses through modulation of the ubiquitination status of central components in NF-κB (nuclear factor κB), IRF3 (interferon regulatory factor 3) and apoptosis signalling cascades. The phenotype of mice with full or conditional A20 deletion illustrates that A20 expression is essential to prevent chronic inflammation and autoimmune pathology. In addition, polymorphisms within the A20 genomic locus have been associated with multiple inflammatory and autoimmune disorders, including SLE (systemic lupus erythaematosis), RA (rheumatoid arthritis), Crohn's disease and psoriasis. A20 has also been implicated as a tumour suppressor in several subsets of B-cell lymphomas. The present review outlines recent findings that illustrate the effect of A20 defects in disease pathogenesis and summarizes the identified A20 polymorphisms associated with different immunopathologies.
Similar articles
-
Single nucleotide polymorphisms at the TNFAIP3/A20 locus and susceptibility/resistance to inflammatory and autoimmune diseases.Adv Exp Med Biol. 2014;809:163-83. doi: 10.1007/978-1-4939-0398-6_10. Adv Exp Med Biol. 2014. PMID: 25302371 Review.
-
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Trends Immunol. 2009. PMID: 19643665 Review.
-
Expression, biological activities and mechanisms of action of A20 (TNFAIP3).Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Biochem Pharmacol. 2010. PMID: 20599425 Review.
-
Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.Clin Exp Immunol. 2016 May;184(2):183-96. doi: 10.1111/cei.12764. Epub 2016 Feb 23. Clin Exp Immunol. 2016. PMID: 26724675 Free PMC article.
-
A20 in inflammation and autoimmunity.Trends Immunol. 2014 Jan;35(1):22-31. doi: 10.1016/j.it.2013.10.005. Epub 2013 Nov 15. Trends Immunol. 2014. PMID: 24246475 Review.
Cited by
-
Induction of the inflammatory regulator A20 by gibberellic acid in airway epithelial cells.Br J Pharmacol. 2016 Feb;173(4):778-89. doi: 10.1111/bph.13200. Epub 2015 Jul 21. Br J Pharmacol. 2016. PMID: 26013851 Free PMC article.
-
Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.Clin Exp Immunol. 2015 Jun;180(3):458-66. doi: 10.1111/cei.12606. Clin Exp Immunol. 2015. PMID: 25683200 Free PMC article.
-
Identification and Classification of Differentially Expressed Genes and Network Meta-Analysis Reveals Potential Molecular Signatures Associated With Tuberculosis.Front Genet. 2019 Nov 4;10:932. doi: 10.3389/fgene.2019.00932. eCollection 2019. Front Genet. 2019. PMID: 31749827 Free PMC article.
-
A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model.Cerebellum. 2024 Feb;23(1):181-196. doi: 10.1007/s12311-023-01524-6. Epub 2023 Feb 2. Cerebellum. 2024. PMID: 36729270
-
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.Cell Death Differ. 2017 Jul;24(7):1172-1183. doi: 10.1038/cdd.2017.46. Epub 2017 Mar 31. Cell Death Differ. 2017. PMID: 28362430 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
